Aida Emirova

Statistics

Publications

Citations

178

H-Index

Active since

2019

Affiliations

Medicines Evaluation Unit(Current)

Chiesi (Italy)

Manchester University NHS Foundation Trust

German Center for Lung Research

Respiratory Research Institute

Aida Emirova is an author at Medicines Evaluation Unit specializing in chronic obstructive pulmonary disease, phosphodiesterase-4 inhibitors, and bronchodilator therapy.

ORCID

Publications per year

2019–2020

Publications

Effect of the inhaled PDE4 inhibitor CHF6001 on biomarkers of inflammation in COPD

Dave Singh, Kai Michael Beeh, Brendan Colgan et al. · Respiratory Research · 2019 · 80 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Efficacy and safety of CHF6001, a novel inhaled PDE4 inhibitor in COPD: the PIONEER study

Dave Singh, Aida Emirova, Catherine Francisco et al. · Respiratory Research · 2020 · 46 citations · Full text

Medicine, Clinical Sciences, Pharmacology +16

Sputum and blood transcriptomics characterisation of the inhaled PDE4 inhibitor CHF6001 on top of triple therapy in patients with chronic bronchitis

Mirco Govoni, Michele Bassi, Stefano Vezzoli et al. · Respiratory Research · 2020 · 32 citations · Full text

Life Sciences, Molecular Biology, Molecular Medicine +17

COPD patients with chronic bronchitis and higher sputum eosinophil counts show increased type‐2 and PDE4 gene expression in sputum

Dave Singh, Michele Bassi, Deborah Balzano et al. · Journal of Cellular and Molecular Medicine · 2020 · 20 citations · Full text

Medicine, Immunology, Pharmacology +17

1–4 of 4